Global Spending on Orphan Drugs in France, Germany, the UK, Italy and Spain during 2007

By Orofino Javier  

Applied Health Economics and Health Policy, Vol. 8, Iss. 5, 2010-09 ,pp. : 301-315

Adis International

Access to resources Recommend Favorite

Healthcare Reforms in Germany: Managed Care, An Opportunity?

By Rychlik R.  

Disease Management & Health Outcomes, Vol. 8, Iss. 6, 2000-12 ,pp. : 305-312

Adis International

Access to resources Recommend Favorite

Health-care reforms in the People's Republic of China: Strategies and social implications

By Wong Victor C.W.   Chiu Sammy W.S.  

Journal of Management in Medicine, Vol. 12, Iss. 4-5, 1998-04 ,pp. : 270-286

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Health-care reforms in the Czech Republic

By Earl-Slater Alan  

Journal of Management in Medicine, Vol. 10, Iss. 2, 1996-02 ,pp. : 13-22

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Affordability of Medicines and Patients’ Cost-Reducing Behaviour: Empirical Evidence Based on SUR Estimates from Italy and the UK

By Atella Vincenzo  

Applied Health Economics and Health Policy, Vol. 4, Iss. 1, 2005-01 ,pp. : 23-35

Adis International

Access to resources Recommend Favorite